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Abstract
Down syndrome is one of the most common genetic
conditions in the world, with a prevalence of 1 in 700. Down
syndrome is caused by an additional copy of chromosome 21.
Although all individuals with Down Syndrome have an extra
copy of chromosome 21, the clinical outcome of Down
Syndrome varies. Why is this? One possibility is that
disruption of other genes that are not on chromosome 21 also
contributes to the clinical outcome. I have identified a strong
genetic candidate called NPHP1 that disrupts a structure
called the primary cilium—a vital signaling structure that is
essential for human development. Since Down syndrome also
causes cilia defects, this raises the possibility that disruption
of the gene NPHP1 makes cilia defects more severe in
individuals with Down syndrome. To test if NPHP1 disruption
combines with an additional copy of chromosome 21 to alter
primary cilium function, I will examine how NPHP1
expression alters cilia in control cells and Down Syndrome
cells. I hypothesize that mutations in NPHP1, combined with
an extra copy of chromosome 21, increase cilia defects in cells
from Down syndrome individuals. If NPHP1 mislocalizes in
Down Syndrome cells as compared to control cells, then
NPHP1 varies the clinical outcome of Down Syndrome.

Introduction to primary cilia

Seeley, E. S., & Nachury, M. V. (2010). The perennial
organelle: Assembly and disassembly of the primary
cilium. Journal of Cell Science, 123(4), 511-518.

A.

The primary cilium is required for individual cells to develop
into multi-cellular organisms (Satir and Christensen, 2007).
Defects in the function and formation of the primary cilium
often result in problems with development (Satir and
Christensen, 2007). Primary cilia are important for
development because primary cilia function as cellular
antennae that receive information from other cells (Gerdes et
al, 2009). Therefore, when ciliary signaling is disrupted proper
developmental patterning does not occur within the individual
(Reiter & Leroux, 2017).

Primary cilia dysfunction in Down syndrome
Down syndrome is caused by an extra copy of chromosome 21
(Hattori et al, 2000). An extra copy of chromosome 21 causes
defects in a cellular structure called the primary cilium (Galati
et al, 2018). It has been shown that over expression of a ciliary
protein found on chromosome 21, pericentrin (PCNT),
disrupts the formation of primary cilia (Galati et al, 2018).
Individuals with Down syndrome have a wide range of clinical
outcomes that differentially impact the development of the
heart, the brain and the skeletal system (Ramachandran et al,
2014). I am interested in understanding the cellular origin of
these developmental differences and whether they relate to
primary cilia. One possible explanation for why an extra copy
of chromosome 21 causes a variety of clinical outcomes is that
the ultimate disease outcome depends upon other genetic
mutations in the individual. This concept is known as the
genetic modifier hypothesis and it has been proposed for
Down syndrome (Li et al, 2012). To identify candidate genes
that could modify
b.Down syndrome outcomes, I have been
focusing on finding genes that, when mutated, could combine
with an extra copy of chromosome 21 to cause more severe
cilia defects.

Plan of attack
The first aim was to identify a candidate gene that may modify
the cilia phenotype in Down syndrome cells. To complete this
aim, I used a combination of bioinformatics and literature
searching, to identify candidate cilia genes that may combine
with an extra copy of chromosome 21 to increase cilia defects.
This approach led to the identification of the gene NPHP1 (Fig.
1). The second aim is to test whether NPHP1 modifies the cilia
phenotype in Down syndrome cells using the cilia assay
described in Figures 2 & 3. To complete this aim I will first
completely reduce expression of NPHP1 to observe presence of
a modified cilia phenotype. Then, I will reduce expression of
NPHP1 to 50% to observe a mild cilia phenotype as compared
to the completely reduced NPHP1 phenotype. Next, I will
increase PCNT expression to observe a modified cilia
phenotype. Lastly, I will examine if an increase of PCNT AND
a reduction of NPHP1 expression cause a stronger
modification in cilia phenotype than the phenotypes caused by
reduced NPHP1 or increased PCNT alone. If a stronger
modification in phenotype is noted, I will examine NPHP1
localization when NPHP1 expression is reduced and PCNT
expression is increased to determine why or how localization
changes and creates a stronger modification in cilia phenotype.

Finding a candidate gene (Figure 1)

B.

Find proteins that are localized to the primary cilium or
centrosomes using the centrosome and cilia database
(CCDB)

1555 genes in CCDB
97 genes interact with
PCNT
93 genes pathogenic in
OMIM or ClinVar

Of these proteins, find which ones interact with
pericentrin (PCNT) by reviewing literature.

Filter out the proteins from chromosome 21.

Mutation is correlated with
congenital heart defects in
individuals with Down
syndrome: RAB21, WDR53,
NPHP1

NPHP1
Using OMIM* and ClinVar**, narrow down proteins that
C.
are pathogenic when mutated.

NPHP1 localization
Immotile canine renal
MDCK cilia. NPHP1 is
labeled in red and cilia
are labeled in green.
Scale bar is 5um.

Find which of these proteins that when mutated also
worsen the clinical outcome of Down syndrome

Nucleus Golgi Cilia (630X)

Omran, H. (2010). NPHP proteins: Gatekeepers
of the ciliary compartment: Figure 1.
The Journal of Cell Biology, 190(5), 715717.

(Zoomed out)

(Zoomed in)

a.
* “OMIM is a
comprehensive,
authoritative
compendium of human
genes and genetic
phenotypes that is freely
available and updated
daily.”
** “ClinVar aggregates
information about
genomic variation and its
relationship to human
health.”
-NCBI, US National
Library of Medicine

Cilia assay for quantifying
number and length of cilia
To quantify cilia, I first find the
number of mouse 3T3 fibroblast
cells with cilia. On only those cells
with cilia, I quantify cilia length. For
example, in Figure 2 there are 10
cells pictured. Of those 10 cells, 7
have cilia (yellow boxes). Figure 3
demonstrates the ability to quantify
actual cilia length in micrometers.
Fig. 3a shows no cilia, Fig. 3b shows
a short cilium at 1.309 um, and Fig.
3c shows a long cilium at 2.964 um.

1.309 um

b.

2.964 um

10 um

Figure 2

c.

Figure 3
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